Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 115 of 115 entries
Sorted by: Best Match Show Resources per page
Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique.

Current opinion in oncology

Eriksson AGZ, Mueller JJ.
PMID: 34264897
Curr Opin Oncol. 2021 Sep 01;33(5):457-463. doi: 10.1097/CCO.0000000000000777.

PURPOSE OF REVIEW: During the last few years there have been important advances in our understanding of endometrial cancer biology, staging, and therapy. In this article, we discuss updates and controversies in the treatment of nonendometrioid endometrial carcinoma (non-EEC),...

Cite
Eriksson AGZ, Mueller JJ. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique. Curr Opin Oncol. 2021;33(5):457-463doi: 10.1097/CCO.0000000000000777.
Eriksson, A. G. Z., & Mueller, J. J. (2021). Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique. Current opinion in oncology, 33(5), 457-463. https://doi.org/10.1097/CCO.0000000000000777
Eriksson, Ane Gerda Z, and Mueller, Jennifer J. "Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique." Current opinion in oncology vol. 33,5 (2021): 457-463. doi: https://doi.org/10.1097/CCO.0000000000000777
Eriksson AGZ, Mueller JJ. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique. Curr Opin Oncol. 2021 Sep 01;33(5):457-463. doi: 10.1097/CCO.0000000000000777. PMID: 34264897.
Copy Download .nbib Format: NLM
New developments in rare vulvar and vaginal cancers.

Current opinion in oncology

Garganese G, Romito A, Scambia G, Fagotti A.
PMID: 34319290
Curr Opin Oncol. 2021 Sep 01;33(5):485-492. doi: 10.1097/CCO.0000000000000757.

PURPOSE OF REVIEW: To provide the latest insight on the rare vulvar and vaginal malignancies, able to impact on clinical practice, and to outline new potential research developments.RECENT FINDINGS: Many efforts are being made to produce technical and scientific...

Cite
Garganese G, Romito A, Scambia G, et al. New developments in rare vulvar and vaginal cancers. Curr Opin Oncol. 2021;33(5):485-492doi: 10.1097/CCO.0000000000000757.
Garganese, G., Romito, A., Scambia, G., & Fagotti, A. (2021). New developments in rare vulvar and vaginal cancers. Current opinion in oncology, 33(5), 485-492. https://doi.org/10.1097/CCO.0000000000000757
Garganese, Giorgia, et al. "New developments in rare vulvar and vaginal cancers." Current opinion in oncology vol. 33,5 (2021): 485-492. doi: https://doi.org/10.1097/CCO.0000000000000757
Garganese G, Romito A, Scambia G, Fagotti A. New developments in rare vulvar and vaginal cancers. Curr Opin Oncol. 2021 Sep 01;33(5):485-492. doi: 10.1097/CCO.0000000000000757. PMID: 34319290.
Copy Download .nbib Format: NLM
Hepatosplenic T-cell lymphoma: treatment challenges.

Current opinion in oncology

Bron D, De Leval L, Michiels S, Wittnebel S.
PMID: 34409955
Curr Opin Oncol. 2021 Sep 01;33(5):406-411. doi: 10.1097/CCO.0000000000000775.

PURPOSE OF REVIEW: Hepatosplenic lymphoma (HSTCL) is a rare T-cell malignancy occurring in young males, associated with immune deficiency in 20% of the cases which, despite aggressive treatments, has a poor survival. Specific recommendations for first-line treatment remain debatable.RECENT...

Cite
Bron D, De Leval L, Michiels S, et al. Hepatosplenic T-cell lymphoma: treatment challenges. Curr Opin Oncol. 2021;33(5):406-411doi: 10.1097/CCO.0000000000000775.
Bron, D., De Leval, L., Michiels, S., Wittnebel, S. (2021). Hepatosplenic T-cell lymphoma: treatment challenges. Current opinion in oncology, 33(5), 406-411. https://doi.org/10.1097/CCO.0000000000000775
Bron, Dominique, et al. "Hepatosplenic T-cell lymphoma: treatment challenges." Current opinion in oncology vol. 33,5 (2021): 406-411. doi: https://doi.org/10.1097/CCO.0000000000000775
Bron D, De Leval L, Michiels S, Wittnebel S. Hepatosplenic T-cell lymphoma: treatment challenges. Curr Opin Oncol. 2021 Sep 01;33(5):406-411. doi: 10.1097/CCO.0000000000000775. PMID: 34409955.
Copy Download .nbib Format: NLM
Bibliography. Current world literature. Prevention.

Current opinion in oncology

[No authors listed]
PMID: 10505786
Curr Opin Oncol. 1999 Sep;11(5):B208-18.

No abstract available.

Cite
Bibliography. Current world literature. Prevention. Curr Opin Oncol. 1999;11(5):B208-18
(1999). Bibliography. Current world literature. Prevention. Current opinion in oncology, 11(5), B208-18.
"Bibliography. Current world literature. Prevention." Current opinion in oncology vol. 11,5 (1999): B208-18.
Bibliography. Current world literature. Prevention. Curr Opin Oncol. 1999 Sep;11(5):B208-18. PMID: 10505786.
Copy Download .nbib Format: NLM
Cancer biology.

Current opinion in oncology

Lengauer C.
PMID: 11148687
Curr Opin Oncol. 2001 Jan;13(1):57. doi: 10.1097/00001622-200101000-00011.

No abstract available.

Cite
Lengauer C. Cancer biology. Curr Opin Oncol. 2001;13(1):57doi: 10.1097/00001622-200101000-00011.
Lengauer, C. (2001). Cancer biology. Current opinion in oncology, 13(1), 57. https://doi.org/10.1097/00001622-200101000-00011
Lengauer. "Cancer biology." Current opinion in oncology vol. 13,1 (2001): 57. doi: https://doi.org/10.1097/00001622-200101000-00011
Lengauer C. Cancer biology. Curr Opin Oncol. 2001 Jan;13(1):57. doi: 10.1097/00001622-200101000-00011. PMID: 11148687.
Copy Download .nbib Format: NLM
Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer.

Current opinion in oncology

Li Y, Hu L, Xu C.
PMID: 34690284
Curr Opin Oncol. 2022 Jan 01;34(1):66-76. doi: 10.1097/CCO.0000000000000808.

PURPOSE OF REVIEW: The unique structure made Kirsten rat sarcoma (KRAS) 'undruggable' for quite an extended period. The functional mechanism of this small protein is well illustrated. However, there is no precision medicine for nonsmall cell lung cancer (NSCLC)...

Cite
Li Y, Hu L, Xu C. Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer. Curr Opin Oncol. 2022;34(1):66-76doi: 10.1097/CCO.0000000000000808.
Li, Y., Hu, L., & Xu, C. (2022). Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer. Current opinion in oncology, 34(1), 66-76. https://doi.org/10.1097/CCO.0000000000000808
Li, Yunchang, et al. "Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer." Current opinion in oncology vol. 34,1 (2022): 66-76. doi: https://doi.org/10.1097/CCO.0000000000000808
Li Y, Hu L, Xu C. Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer. Curr Opin Oncol. 2022 Jan 01;34(1):66-76. doi: 10.1097/CCO.0000000000000808. PMID: 34690284.
Copy Download .nbib Format: NLM
Challenges adopting next-generation sequencing in community oncology practice.

Current opinion in oncology

Ashbury FD, Thompson K, Williams C, Williams K.
PMID: 34183492
Curr Opin Oncol. 2021 Sep 01;33(5):507-512. doi: 10.1097/CCO.0000000000000764.

PURPOSE OF REVIEW: We are in an exhilarating time in which innovations exist to help reduce the impact of cancer for individuals, practitioners and society. Innovative tools in cancer genomics can optimize decision-making concerning appropriate drugs (alone or in...

Cite
Ashbury FD, Thompson K, Williams C, et al. Challenges adopting next-generation sequencing in community oncology practice. Curr Opin Oncol. 2021;33(5):507-512doi: 10.1097/CCO.0000000000000764.
Ashbury, F. D., Thompson, K., Williams, C., & Williams, K. (2021). Challenges adopting next-generation sequencing in community oncology practice. Current opinion in oncology, 33(5), 507-512. https://doi.org/10.1097/CCO.0000000000000764
Ashbury, Fredrick D, et al. "Challenges adopting next-generation sequencing in community oncology practice." Current opinion in oncology vol. 33,5 (2021): 507-512. doi: https://doi.org/10.1097/CCO.0000000000000764
Ashbury FD, Thompson K, Williams C, Williams K. Challenges adopting next-generation sequencing in community oncology practice. Curr Opin Oncol. 2021 Sep 01;33(5):507-512. doi: 10.1097/CCO.0000000000000764. PMID: 34183492.
Copy Download .nbib Format: NLM
Showing 109 to 115 of 115 entries